Cannabis Insider: Expert Predicts FDA Will 'Legitimize' CBD By End Of Next Year
Sheri Orlowitz, founder and managing director of the Council for Federal Cannabis Regulation (CFCR), a non-profit based in Washington, DC., told Cannabis Insider’s Elliot Lane that she predicts by the end of 2023, CBD will likely be moved from its onerous Schedule I status.
